Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood plasma injections show promise for back pain relief

NCT ID NCT07268885

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a procedure called 'PRP Spinoplasty' for people with long-term lower back pain from disc disease, facet joint arthritis, and muscle spasms. 35 adults who had not improved with standard care received injections of platelet-rich plasma (PRP) into multiple areas of the spine. Researchers measured pain levels and disability before and after treatment to see if the approach was safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Platelet Rich Plasma (PRP)
What this could lead to
If it works, this could offer a new injection-based option to ease chronic lower back pain and improve function without surgery.
What could go wrong
This is a small, early-phase study with only 35 people and no comparison group, so results may not apply broadly. PRP injections can cause temporary pain or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

35 people

The number who actually took part.

Started

Sep 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals of both sexes; ages between 18 and 80 years. * Lower back pain consistent with lumbosacral radiculopathy, facet arthropathy, and muscle spasms. * MRI-confirmed lumbar spine pathology (disc disease and/or facet arthropathy). * Failure to respond to at least 3 months of conservative therapy (NSAIDS and physical therapy). * Pain score ≥ 6; on the 10-point Numeric Pain Scale (NPS) at baseline. Exclusion Criteria: * Presence of local or systemic infection, or fever. * Diagnosed with cancer within the past 12 months. * Unable to give a consent. * History of spinal deformity such as fracture, or severe spinal stenosis causing neurological deficit. * Presence of lower extremity weakness or urinary tract symptoms related to spinal pathology. * Previous spinal decompression or fusion surgery at the treatment level. * Receipt of any spine injection within the previous 12 months. * Use of NSAIDs within 2 weeks prior to, or 6 weeks following the procedure. * Use of corticosteroids within 6 weeks prior, or after the procedure. * Use of anticoagulation or antiplatelet drugs (excluding low-dose Aspirin). * History of blood disorders. * History of any major surgery within the past 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facet joint arthritis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Allmed Medical Center

    Ramallah, Palestinian Territories

More trials for these conditions

Other studies related to the condition(s) this trial covers.